Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ビューラックA (Beauluck A) is an over-the-counter (OTC) stimulant laxative developed and marketed by Kokando Pharmaceutical in Japan. Its active ingredient is bisacodyl, a small molecule that directly stimulates the colonic mucosa to promote peristaltic movement of the large intestine. The drug is formulated as an enteric-coated tablet, which prevents it from dissolving in the stomach and allows it to act specifically within the intestines. It is indicated for the treatment of constipation and the relief of associated symptoms such as abdominal bloating, loss of appetite, and skin eruptions. It is classified as a Class 2 OTC medicine in Japan and is typically administered before bedtime to produce results the following morning.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ビューラックA.